Ocrevus as a first-line treatment for early relapsing MS is better at delaying disease progression than starting with a less effective drug.

Intrommune Therapeutics, Inc. is excited to announce the publication of a its Phase 1 OMEGA (Oral Mucosal Escalation Goal Assessment) study evaluating the safety, tolerability, and adherence of a ...

YPrime's enhanced eCOA localization capabilities address this need by providing a seamless, efficient process for implementing multilingual deployments. The company's innovative new approach empowers ...

Dr Ioannis Tosounidis was struck off the medical register in 2014 after numerous mistakes and repeated dishonesty ...

Thousands of Yorkshire families are waiting months longer than recommended time for an autism assessment. According to the ...

Assessment of liver fibrosis and cirrhosis is crucial for the management of patients with chronic hepatitis B. The presence of at least moderate liver fibrosis is an important indication for antiviral ...